share_log

Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga ·  Feb 26 07:03

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

Shares of Li Auto Inc. (NASDAQ:LI) rose sharply in today's pre-market trading after the company reported fourth-quarter financial results above estimates and issued first-quarter guidance.

Li Auto posted adjusted earnings of 30 cents per share, beating market estimates of 29 cents per share. The company's quarterly sales came in at $5.88 billion versus expectations of $5.48 billion.

Li Auto shares surged 8% to $37.56 in pre-market trading.

Here are some big stocks recording gains in today's pre-market trading session.

  • ImmunityBio, Inc. (NASDAQ:IBRX) shares climbed 12.3% to $3.93 in pre-market trading after dipping 33% on Friday.
  • Bowlero Corp. (NYSE:BOWL) shares gained 6.5% to $13.05 in pre-market trading.
  • Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares gained 5.3% to $13.57 in pre-market trading. Alvotech and Teva announced the U.S. approval of SIMLANDI (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira.
  • Amer Sports, Inc. (NYSE:AS) shares gained 5.2% to $16.34 in pre-market trading after adding over 3% on Friday.
  • SES AI Corporation (NYSE:SES) shares climbed 5.1% to $1.45 in pre-market trading. SES AI is expected to release its 2023 fourth quarter business results after the closing bell on Feb. 26, 2024.
  • Berkshire Hathaway Inc. (NYSE: BRK-B) shares rose 5% to $438.08 in pre-market trading. Warren Buffett Said Berkshire is expected to maintain its investment in Occidental Petroleum indefinitely.
  • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares rose 4.9% to $5.99 in pre-market trading. BioCryst Pharmaceuticals is projected to report its fourth quarter 2023 financial results on Feb. 26, 2024.

Now Read This: Investor Sentiment Edges Lower, But Fear & Greed Index Remains In 'Extreme Greed' Zone

Don't forget to check out our premarket coverage here

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment